NewSquare Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $399K | Buy |
1,836
+231
| +14% | +$51.2K | 0.03% | 167 |
|
|
2025
Q4 | $367K | Sell |
1,605
-514
| -24% | -$117K | 0.03% | 161 |
|
|
2025
Q3 | $491K | Buy |
2,119
+393
| +23% | +$80K | 0.03% | 156 |
|
|
2025
Q2 | $320K | Buy |
1,726
+638
| +59% | +$119K | 0.02% | 161 |
|
|
2025
Q1 | $228K | Buy |
1,088
+557
| +105% | +$108K | 0.02% | 171 |
|
|
2024
Q4 | $94.4K | Buy |
531
+530
| +53,000% | +$97.4K | 0.01% | 175 |
|
|
2024
Q3 | $189 | Hold |
1
| – | – | ﹤0.01% | 300 |
|
|
2024
Q2 | $164 | Sell |
1
-373
| -100% | -$61.8K | ﹤0.01% | 315 |
|
|
2024
Q1 | $68.1K | Sell |
374
-22
| -6% | -$3.79K | 0.01% | 166 |
|
|
2023
Q4 | $61.4K | Sell |
396
-45
| -10% | -$6.56K | 0.01% | 181 |
|
|
2023
Q3 | $65.7K | Sell |
441
-66
| -13% | -$9.69K | 0.01% | 187 |
|
|
2023
Q2 | $68.3K | Sell |
507
-340
| -40% | -$49.9K | 0.01% | 186 |
|
|
2023
Q1 | $135K | Buy |
847
+316
| +60% | +$48.3K | 0.02% | 160 |
|
|
2022
Q4 | $85.8K | Sell |
531
-307
| -37% | -$47.1K | 0.01% | 163 |
|
|
2022
Q3 | $112K | Buy |
838
+1
| +0.1% | +$143 | 0.01% | 156 |
|
|
2022
Q2 | $128K | Sell |
837
-31,093
| -97% | -$4.75M | 0.02% | 162 |
|
|
2022
Q1 | $5.18M | Buy |
31,930
+30,866
| +2,901% | +$4.48M | 0.55% | 42 |
|
|
2021
Q4 | $144K | Hold |
1,064
| – | – | 0.02% | 170 |
|
|
2021
Q3 | $115K | Sell |
1,064
-4,865
| -82% | -$556K | 0.01% | 178 |
|
|
2021
Q2 | $668K | Buy |
5,929
+219
| +4% | +$24.7K | 0.08% | 131 |
|
|
2021
Q1 | $618K | Buy |
5,710
+5,380
| +1,630% | +$575K | 0.08% | 124 |
|
|
2020
Q4 | $35K | Hold |
330
| – | – | ﹤0.01% | 186 |
|
|
2020
Q3 | $29K | Sell |
330
-27
| -8% | -$2.54K | ﹤0.01% | 185 |
|
|
2020
Q2 | $35K | Sell |
357
-818
| -70% | -$72K | 0.01% | 178 |
|
|
2020
Q1 | $90K | Buy |
1,175
+759
| +182% | +$64.6K | 0.02% | 153 |
|
|
2019
Q4 | $37K | Hold |
416
| – | – | 0.01% | 184 |
|
|
2019
Q3 | $31K | Hold |
416
| – | – | 0.01% | 157 |
|
|
2019
Q2 | $30K | Sell |
416
-20,085
| -98% | -$1.58M | 0.01% | 199 |
|
|
2019
Q1 | $1.65M | Buy |
20,501
+939
| +5% | +$76.8K | 0.32% | 61 |
|
|
2018
Q4 | $1.8M | Buy |
19,562
+137
| +0.7% | +$12K | 0.38% | 39 |
|
|
2018
Q3 | $1.84M | Buy |
19,425
+1,329
| +7% | +$126K | 0.35% | 48 |
|
|
2018
Q2 | $1.61M | Buy |
18,096
+1,880
| +12% | +$184K | 0.33% | 54 |
|
|
2018
Q1 | $1.53M | Sell |
16,216
-341
| -2% | -$37.5K | 0.33% | 45 |
|
|
2017
Q4 | $1.6M | Sell |
16,557
-90
| -0.5% | -$8.48K | 0.37% | 41 |
|
|
2017
Q3 | $1.48M | Buy |
16,647
+4
| +0% | +$304 | 0.35% | 40 |
|
|
2017
Q2 | $1.21M | Buy |
16,643
+777
| +5% | +$52.2K | 0.29% | 50 |
|
|
2017
Q1 | $1.03M | Buy |
15,866
+2,340
| +17% | +$147K | 0.25% | 59 |
|
|
2016
Q4 | $847K | Buy |
13,526
+344
| +3% | +$21K | 0.21% | 76 |
|
|
2016
Q3 | $831K | Buy |
13,182
+736
| +6% | +$47.6K | 0.19% | 78 |
|
|
2016
Q2 | $771K | Buy |
12,446
+1,596
| +15% | +$97.3K | 0.18% | 73 |
|
|
2016
Q1 | $620K | Buy |
10,850
+5,725
| +112% | +$319K | 0.18% | 84 |
|
|
2015
Q4 | $304K | Buy |
5,125
+667
| +15% | +$38.4K | 0.09% | 106 |
|
|
2015
Q3 | $243K | Buy |
4,458
+96
| +2% | +$6.25K | 0.07% | 102 |
|
|
2015
Q2 | $293K | Buy |
4,362
+95
| +2% | +$6.2K | 0.09% | 99 |
|
|
2015
Q1 | $250K | Buy |
4,267
+222
| +5% | +$13.4K | 0.08% | 100 |
|
|
2014
Q4 | $265K | Buy |
4,045
+133
| +3% | +$8.38K | 0.09% | 104 |
|
|
2014
Q3 | $226K | Buy |
3,912
+349
| +10% | +$19.4K | 0.08% | 113 |
|
|
2014
Q2 | $201K | Buy |
+3,563
| New | +$187K | 0.07% | 114 |
|
|
2014
Q1 | – | Sell |
-3,576
| Closed | -$189K | – | 238 |
|
|
2013
Q4 | $189K | Buy |
3,576
+286
| +9% | +$14.1K | 0.09% | 87 |
|
|
2013
Q3 | $147K | Sell |
3,290
-98
| -3% | -$4.34K | 0.07% | 95 |
|
|
2013
Q2 | $140K | Buy |
+3,388
| New | +$148K | 0.07% | 93 |
|
Other funds holding ABBV
VCM
VPM
NewSquare Capital's ABBV Position: Q1 2026 in Review
NewSquare Capital increased its AbbVie (ABBV) stake by 14% in Q1 2026, buying an estimated $51.2K and bringing the position to 1,836 shares worth $399K. The position accounts for 0.03% of the portfolio, ranked #167.
NewSquare Capital first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.18M in Q1 2022. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- NewSquare Capital held 1,836 shares of AbbVie worth $399K as of Q1 2026.
- NewSquare Capital bought 231 AbbVie shares in Q1 2026, an estimated $51.2K.
- AbbVie made up 0.03% of NewSquare Capital's portfolio in Q1 2026, its #167 holding.
- NewSquare Capital first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- NewSquare Capital's AbbVie position peaked at $5.18M in Q1 2022.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on NewSquare Capital's 13F filing for Q1 2026, filed 8 May 2026.